Ideal Implant
Ideal Implant developed a proprietary dual-lumen structured saline breast implant offering silicone-like aesthetics with saline safety, FDA Class III approved. Acquired by Bimini Health Tech in 2023 and rebranded as Serene Breast Implant, serving plastic and reconstructive surgeons.
- Company typePrivate
- Founded2006
- HeadquartersDallas, United States
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What Ideal Implant does
Ideal Implant Inc., founded in 2006 and headquartered in Plano, Texas, is a medical device company that developed, manufactured, and marketed a proprietary structured saline breast implant designed to deliver the natural look and feel of silicone with the safety profile of saline. Its core technology is a dual-lumen design comprising a smooth silicone inner shell and a smooth silicone outer shell, each filled with saline via separate valves, separated by one to three nested baffle shells perforated with slits that control saline movement and reinforce implant edges. The device received one of the few U.S. FDA Class III approvals for structured saline breast implants and demonstrated lower capsular contracture and deflation rates in a 10-year clinical study, supported by a Limited Lifetime Warranty.
The company generated revenue through direct hardware sales of breast implants to plastic and reconstructive surgery practices and hospitals, with go-to-market executed via enterprise field sales targeting board-certified plastic surgeons and supporting surgeon education, IFUs, sizing tools, and a device-tracking program. Following its August 2023 acquisition by Bimini Health Tech, Ideal Implant was rebranded as the Serene Breast Implant and integrated into a broader Bimini portfolio that now includes PureGraft fat grafting, Essence ADM acellular dermal matrix, Dermapose dermal tissue, Healeon PRP, and the Kerastem hair restoration pipeline product. The combined product set is manufactured under ISO 13485 and MDSAP quality systems and is distributed globally through Bimini's commercial operations.
Robert S. Hamas serves as President, CEO, and Founder of the legacy entity. Ideal Implant had raised approximately $7.56M across five known funding rounds between 2011 and 2018 prior to the Bimini transaction, and operated with 11–50 employees as a privately held subsidiary post-acquisition.
Ideal Implant firmographics
Firmographics- Name
- Ideal Implant
- Legal name
- Ideal Implant Inc.
- Website
- https://idealimplant.com
- Company type
- Private
- Founded year
- 2006
- Operating status
- Acquired
- Headcount range
- 11–50 employees
- Short description
- Ideal Implant developed a proprietary dual-lumen structured saline breast implant offering silicone-like aesthetics with saline safety, FDA Class III approved. Acquired by Bimini Health Tech in 2023 and rebranded as Serene Breast Implant, serving plastic and reconstructive surgeons.
- Ownership category
- akta.pro rank
Where Ideal Implant is headquartered
LocationHeadquarters
- HQ city
- Dallas
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Ideal Implant business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Operations, Technology or R&D, Marketing or Sales, Personnel
Revenue model
- Breast Implant Sales: Sale of structured saline breast implants to plastic and reconstructive surgery practices and hospitals worldwide through Bimini Health Tech's distribution network following the August 2023 acquisition.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels1 record
Ideal Implant product offering
Product offeringCore offering
Ideal Implant Inc. develops, manufactures, and markets structured saline-filled breast implants for cosmetic and reconstructive surgery. Following its August 2023 acquisition by Bimini Health Tech, the technology was rebranded as the Serene Breast Implant and continues to be sold to plastic and reconstructive surgeons worldwide through Bimini's distribution network. The flagship product features an innovative dual-lumen design with internal nested baffle shells that deliver the look and feel of silicone with the safety profile of saline.
Product overview
Ideal Implant, now part of Bimini Health Tech following an August 2023 acquisition, offers a portfolio of medical devices for plastic and reconstructive surgery. The flagship product is the Serene Structured Saline Breast Implant™ (the enhanced evolution of the former Ideal Implant), which features an innovative dual-lumen design with internal baffle shells for natural look and feel. The portfolio also includes PureGraft® fat grafting products, Essence ADM™ acellular dermal matrix, Dermapose® dermal products, Healeon® PRP products, and Kerastem™ in the pipeline. All products are designed to optimize outcomes in plastic and reconstructive surgery.
Differentiator
Problem solved
Functional benefit
Brands
- Serene Breast Implant: Structured saline breast implant with innovative design featuring a smooth silicone inner shell, smooth silicone outer shell, and internal baffle structure. Builds upon the foundation of the former Ideal Implant.
Products and services
- Serene Breast Implant (formerly Ideal Implant) A structured saline breast implant featuring an innovative dual-lumen design with an inner silicone shell and an outer silicone shell separated by nested internal baffle shells; it provides the look and feel of silicone with the safety profile of saline and is sold to plastic and reconstructive surgeons for breast augmentation, reconstruction, and revision procedures.
Quantifiable outcome
- Lower capsular contracture and deflation rates demonstrated in 10-year clinical study
Companies that use Ideal Implant
Customer profileSegments1 record
Ideal customer profiles1 record
Ideal Implant technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
Ideal Implant partnerships and signals
Strategic signalScale indicators2 records
Recent moves5 records
Expansion highlights5 records
Ideal Implant competitors and assessment
Company assessmentDirect peers
- Sientra: Sientra (now under Tiger Aesthetics/Mirum) sells silicone gel breast implants and was a U.S. challenger breast implant brand that similarly targeted safety and aesthetics differentiation. Directly comparable to Ideal Implant/Serene as a smaller U.S. breast implant specialist competing with Allergan and Mentor.
- GC Aesthetics: GC Aesthetics is a global breast implant and medical aesthetics manufacturer offering the Round and Anatomical collection plus the FixNip nipple-areola complex prosthesis. Closely comparable to Ideal Implant/Serene as an established independent breast implant specialist with international distribution.
- POLYTECH Health & Aesthetics: POLYTECH Health & Aesthetics is a German breast implant manufacturer offering silicone gel and polyurethane-coated implants used globally in aesthetic and reconstructive surgery. Comparable to Ideal Implant/Serene as a specialty breast implant manufacturer competing for share outside the Allergan/Mentor duopoly.
- Establishment Labs (Motiva): Establishment Labs markets the Motiva Ergonomix and Motiva Flora breast implant lines, including smoothSilk and SilkSurface technologies, and is the most direct contemporary challenger to the legacy breast implant duopoly. Comparable to Ideal Implant/Serene as a differentiated, clinically-invested breast implant manufacturer pursuing share against Allergan and Mentor.
Regional players
- Silimed: Silimed is a Brazilian manufacturer of silicone breast implants and other implantables with a strong Latin American and select international presence. Comparable to Ideal Implant/Serene as a competing breast implant specialist from outside the major incumbents, with regional rather than U.S.-centric distribution.
- Sebbin: Sebbin is a French manufacturer of silicone gel breast implants primarily distributed across Europe and select international markets. Comparable to Ideal Implant/Serene as a competing breast implant specialist, though Sebbin's footprint is more Europe-centric compared to the U.S.-anchored Serene product.
- HansBiomed: HansBiomed is a Korean medical device company marketing cohesive gel and micro-textured breast implants primarily across Asia and select international markets. Comparable as an emerging breast implant specialist outside the dominant U.S. incumbents, with regional focus differing from Serene's U.S. anchor.
Others
- Bimini Health Tech: Bimini Health Tech is the parent company of Ideal Implant/Serene and a privately held commercial-stage medical device and biologics company. Included as an OTHERS peer because it represents the corporate owner/distributor rather than a direct product competitor, and offers adjacency to the same plastic and reconstructive surgery customer base.
Broad incumbents
- Allergan Aesthetics (AbbVie): Allergan Aesthetics (now AbbVie) is the other dominant breast implant manufacturer, offering Natrelle silicone gel and saline implants. Direct competition to Ideal Implant/Serene with the largest installed base and brand recognition in U.S. breast augmentation.
- Mentor (Johnson & Johnson): Mentor is one of the two dominant U.S. breast implant manufacturers, part of Johnson & Johnson MedTech, offering the MemoryGel and CPG saline implants. Comparable to Ideal Implant/Serene as a competing breast implant franchise with much broader portfolio, sales force, and surgeon relationships.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks5 records
Key highlights6 records
Customer concentration
Ideal Implant social profiles
Digital presenceIdeal Implant compliance and trust
Trust signalCompliance3 records
Ideal Implant financial estimates
Financial estimateRevenue estimate
Valuation estimate
Ideal Implant leadership team
Management profileNumber of profiles
Profiles1 record
Ideal Implant funding detail
Funding detailFunding overview
Funding rounds5 records
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Ideal Implant M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Ideal Implant
What does Ideal Implant do?
Ideal Implant Inc. develops, manufactures, and markets structured saline-filled breast implants for cosmetic and reconstructive surgery. Following its August 2023 acquisition by Bimini Health Tech, the technology was rebranded as the Serene Breast Implant and continues to be sold to plastic and reconstructive surgeons worldwide through Bimini's distribution network. The flagship product features an innovative dual-lumen design with internal nested baffle shells that deliver the look and feel of silicone with the safety profile of saline.
Is Ideal Implant a public or private company?
Ideal Implant is a private company. It is classified as corporate owned and is currently acquired.
When was Ideal Implant founded?
Ideal Implant was founded in 2006. It employs 11 to 50 people.
Where is Ideal Implant based?
Ideal Implant is headquartered in Dallas, United States, in the North America region.
How does Ideal Implant make money?
One revenue line is on record: breast Implant Sales.
Who are Ideal Implant's main competitors?
Direct peers on record are Sientra, GC Aesthetics, POLYTECH Health & Aesthetics and Establishment Labs (Motiva). Regional players are Silimed, Sebbin and HansBiomed. Bimini Health Tech is listed as an others. Broad incumbents are Allergan Aesthetics (AbbVie) and Mentor (Johnson & Johnson).
Does Ideal Implant have an API?
No public API is recorded for Ideal Implant.